logo
Plus   Neg
Share
Email

Becton, Dickinson Boosts FY21 Outlook - Quick Facts

While reporting preliminary unaudited financial information for the first quarter of fiscal 2021 on Tuesday, medical technology company Becton, Dickinson and Co. or BD (BDX) updated its revenue growth outlook for fiscal 2021.

For fiscal 2021, the company now expects to deliver revenues toward the high-end of its previously communicated guidance range and above the prior adjusted earnings per share guidance range.

Previously, the company had expected adjusted earnings in a range of $12.40 and $12.60 per share on revenue growth in the high single to low double-digits on a percentage basis. This included a contribution of approximately 100 basis points from foreign currency.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $12.52 per share on revenue grown of 11.50 percent to $19.09 billion for the year. Analysts' estimates typically exclude special items.

As per the preliminary unaudited first fiscal quarter 2021 results, the company expects quarterly revenues to increase 25.6% to $5.3 billion for the quarter, primarily due to strong demand for its COVID-19 diagnostic tests and better-than-expected performance across all three segments. On a currency-neutral basis, revenues are expected to increase 24.2% over the prior-year period. The Street is currently looking for revenues of $4.49 billion for the quarter.

For the first quarter, BD expects COVID-19 testing revenues of approximately $865 million, BD Medical segment revenues of $2.3 billion, BD Life Sciences segment revenues of $2.0 billion and BD Interventional segment revenues of $1.1 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Polaris Industries Inc. recalled about 15,800 units of Off-Road and Utility Vehicles in North America for possible crash hazard, according to a statement issued by the U.S. Consumer Product Safety Commission. There were also an additional 711 units sold in Canada. AstraZeneca's efforts to supply Covid-19 vaccine doses from its Italian unit to Australia has been blocked by the European Union and the Italian Government, citing Australia being non-vulnerable region and delays in domestic supply, among others. Italy's proposal to deny AstraZeneca's request for authorization to export COVID-19 vaccines was subsequently approved by the European Commission. Chipotle Mexican Grill, Inc. is teaming with e.l.f. Cosmetics to launch a limited edition beauty collection on March 10, aiming to support plant-based lifestyles and responsibly-sourced products. The e.l.f. x Chipotle makeup collection will comprise cruelty-free and vegan products inspired by Chipotle's responsibly-raised food.
Follow RTT